352 related articles for article (PubMed ID: 24332065)
1. Up-regulation of type I collagen during tumorigenesis of colorectal cancer revealed by quantitative proteomic analysis.
Zou X; Feng B; Dong T; Yan G; Tan B; Shen H; Huang A; Zhang X; Zhang M; Yang P; Zheng M; Zhang Y
J Proteomics; 2013 Dec; 94():473-85. PubMed ID: 24332065
[TBL] [Abstract][Full Text] [Related]
2. Up-regulation of collagen proteins in colorectal liver metastasis compared with normal liver tissue.
van Huizen NA; Coebergh van den Braak RRJ; Doukas M; Dekker LJM; IJzermans JNM; Luider TM
J Biol Chem; 2019 Jan; 294(1):281-289. PubMed ID: 30409905
[TBL] [Abstract][Full Text] [Related]
3. An informatics-assisted label-free approach for personalized tissue membrane proteomics: case study on colorectal cancer.
Han CL; Chen JS; Chan EC; Wu CP; Yu KH; Chen KT; Tsou CC; Tsai CF; Chien CW; Kuo YB; Lin PY; Yu JS; Hsueh C; Chen MC; Chan CC; Chang YS; Chen YJ
Mol Cell Proteomics; 2011 Apr; 10(4):M110.003087. PubMed ID: 21209152
[TBL] [Abstract][Full Text] [Related]
4. Proteomic profiling of a mouse model of acute intestinal Apc deletion leads to identification of potential novel biomarkers of human colorectal cancer (CRC).
Hammoudi A; Song F; Reed KR; Jenkins RE; Meniel VS; Watson AJ; Pritchard DM; Clarke AR; Jenkins JR
Biochem Biophys Res Commun; 2013 Oct; 440(3):364-70. PubMed ID: 23998936
[TBL] [Abstract][Full Text] [Related]
5. Quantitative proteomic analysis of paired colorectal cancer and non-tumorigenic tissues reveals signature proteins and perturbed pathways involved in CRC progression and metastasis.
Sethi MK; Thaysen-Andersen M; Kim H; Park CK; Baker MS; Packer NH; Paik YK; Hancock WS; Fanayan S
J Proteomics; 2015 Aug; 126():54-67. PubMed ID: 26054784
[TBL] [Abstract][Full Text] [Related]
6. Identification and Verification of Two Novel Differentially Expressed Proteins from Non-neoplastic Mucosa and Colorectal Carcinoma Via iTRAQ Combined with Liquid Chromatography-Mass Spectrometry.
Bai Y; Wang J; Gao Z; Dai E
Pathol Oncol Res; 2020 Apr; 26(2):967-976. PubMed ID: 30927204
[TBL] [Abstract][Full Text] [Related]
7. New prognosis biomarkers identified by dynamic proteomic analysis of colorectal cancer.
Peng Y; Li X; Wu M; Yang J; Liu M; Zhang W; Xiang B; Wang X; Li X; Li G; Shen S
Mol Biosyst; 2012 Nov; 8(11):3077-88. PubMed ID: 22996014
[TBL] [Abstract][Full Text] [Related]
8. Plasma miR-183 predicts recurrence and prognosis in patients with colorectal cancer.
Yuan D; Li K; Zhu K; Yan R; Dang C
Cancer Biol Ther; 2015; 16(2):268-75. PubMed ID: 25629978
[TBL] [Abstract][Full Text] [Related]
9. Identification of MST1 as a potential early detection biomarker for colorectal cancer through a proteomic approach.
Yu J; Zhai X; Li X; Zhong C; Guo C; Yang F; Yuan Y; Zheng S
Sci Rep; 2017 Oct; 7(1):14265. PubMed ID: 29079854
[TBL] [Abstract][Full Text] [Related]
10. Epithelial but not stromal expression of collagen alpha-1(III) is a diagnostic and prognostic indicator of colorectal carcinoma.
Wang XQ; Tang ZX; Yu D; Cui SJ; Jiang YH; Zhang Q; Wang J; Yang PY; Liu F
Oncotarget; 2016 Feb; 7(8):8823-38. PubMed ID: 26741506
[TBL] [Abstract][Full Text] [Related]
11. Upregulation of spondin-2 predicts poor survival of colorectal carcinoma patients.
Zhang Q; Wang XQ; Wang J; Cui SJ; Lou XM; Yan B; Qiao J; Jiang YH; Zhang LJ; Yang PY; Liu F
Oncotarget; 2015 Jun; 6(17):15095-110. PubMed ID: 25945835
[TBL] [Abstract][Full Text] [Related]
12. Identification of differentially-expressed proteins between early submucosal non-invasive and invasive colorectal cancer using 2D-DIGE and mass spectrometry.
Zhang J; Song MQ; Zhu JS; Zhou Z; Xu ZP; Chen WX; Chen NW
Int J Immunopathol Pharmacol; 2011; 24(4):849-59. PubMed ID: 22230392
[TBL] [Abstract][Full Text] [Related]
13. A circulating extracellular vesicles-based novel screening tool for colorectal cancer revealed by shotgun and data-independent acquisition mass spectrometry.
Zheng X; Xu K; Zhou B; Chen T; Huang Y; Li Q; Wen F; Ge W; Wang J; Yu S; Sun L; Zhu L; Liu W; Gao H; Yue L; Cai X; Zhang Q; Ruan G; Zhu T; Wu Z; Zhu Y; Shao Y; Guo T; Zheng S
J Extracell Vesicles; 2020; 9(1):1750202. PubMed ID: 32363013
[No Abstract] [Full Text] [Related]
14. Identification of Cystatin SN as a novel tumor marker for colorectal cancer.
Yoneda K; Iida H; Endo H; Hosono K; Akiyama T; Takahashi H; Inamori M; Abe Y; Yoneda M; Fujita K; Kato S; Nozaki Y; Ichikawa Y; Uozaki H; Fukayama M; Shimamura T; Kodama T; Aburatani H; Miyazawa C; Ishii K; Hosomi N; Sagara M; Takahashi M; Ike H; Saito H; Kusakabe A; Nakajima A
Int J Oncol; 2009 Jul; 35(1):33-40. PubMed ID: 19513549
[TBL] [Abstract][Full Text] [Related]
15. UHPLC-HRMS-based Multiomics to Explore the Potential Mechanisms and Biomarkers for Colorectal Cancer.
Wang X; Guan X; Tong Y; Liang Y; Huang Z; Wen M; Luo J; Chen H; Yang S; She Z; Wei Z; Zhou Y; Qi Y; Zhu P; Nong Y; Zhang Q
BMC Cancer; 2024 May; 24(1):644. PubMed ID: 38802800
[TBL] [Abstract][Full Text] [Related]
16. Discovery of melanotransferrin as a serological marker of colorectal cancer by secretome analysis and quantitative proteomics.
Shin J; Kim HJ; Kim G; Song M; Woo SJ; Lee ST; Kim H; Lee C
J Proteome Res; 2014 Nov; 13(11):4919-31. PubMed ID: 25216327
[TBL] [Abstract][Full Text] [Related]
17. Use of iTRAQ-based quantitative proteomic identification of CHGA and UCHL1 correlated with lymph node metastasis in colorectal carcinoma.
Lee KC; Chen HH; Cheng KC; Liu TT; Lee KF; Teng CC; Huang CY; Hsieh MC; Kuo HC
J Cell Mol Med; 2023 Jul; 27(14):2004-2020. PubMed ID: 37246623
[TBL] [Abstract][Full Text] [Related]
18. Role of serum Metadherin mRNA expression in the diagnosis and prediction of survival in patients with colorectal cancer.
Abdel Ghafar MT; Gharib F; Abdel-Salam S; Elkhouly RA; Elshora A; Shalaby KH; El-Guindy D; El-Rashidy MA; Soliman NA; Abu-Elenin MM; Allam AA
Mol Biol Rep; 2020 Apr; 47(4):2509-2519. PubMed ID: 32088817
[TBL] [Abstract][Full Text] [Related]
19. SPON2, a newly identified target gene of MACC1, drives colorectal cancer metastasis in mice and is prognostic for colorectal cancer patient survival.
Schmid F; Wang Q; Huska MR; Andrade-Navarro MA; Lemm M; Fichtner I; Dahlmann M; Kobelt D; Walther W; Smith J; Schlag PM; Stein U
Oncogene; 2016 Nov; 35(46):5942-5952. PubMed ID: 26686083
[TBL] [Abstract][Full Text] [Related]
20. Proteomic screening of potential N-glycoprotein biomarkers for colorectal cancer by TMT labeling combined with LC-MS/MS.
Gong Q; Zhang X; Liang A; Huang S; Tian G; Yuan M; Ke Q; Cai Y; Yan B; Wang J; Wang J
Clin Chim Acta; 2021 Oct; 521():122-130. PubMed ID: 34242638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]